| __timestamp | Agios Pharmaceuticals, Inc. | Pfizer Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 100371000 | 8393000000 |
| Thursday, January 1, 2015 | 141827000 | 7690000000 |
| Friday, January 1, 2016 | 220163000 | 7872000000 |
| Sunday, January 1, 2017 | 292681000 | 7657000000 |
| Monday, January 1, 2018 | 341324000 | 8006000000 |
| Tuesday, January 1, 2019 | 410894000 | 8650000000 |
| Wednesday, January 1, 2020 | 367470000 | 9405000000 |
| Friday, January 1, 2021 | 256973000 | 13829000000 |
| Saturday, January 1, 2022 | 279910000 | 11428000000 |
| Sunday, January 1, 2023 | 288903000 | 10679000000 |
| Monday, January 1, 2024 | 301286000 | 10930000000 |
Unleashing insights
In the ever-evolving landscape of pharmaceutical innovation, research and development (R&D) spending is a key indicator of a company's commitment to future breakthroughs. Over the past decade, Pfizer Inc. and Agios Pharmaceuticals, Inc. have demonstrated contrasting approaches to R&D investment.
From 2014 to 2023, Pfizer's R&D expenses have consistently dwarfed those of Agios, with Pfizer investing nearly 40 times more on average. Notably, Pfizer's R&D spending peaked in 2021, reaching a staggering 13.8 billion dollars, reflecting its aggressive pursuit of new therapies. Meanwhile, Agios, a smaller player, has shown a steady increase in R&D investment, peaking in 2019 with a 41% rise from 2014.
This comparison highlights the diverse strategies within the pharmaceutical industry, where both giants and niche players contribute to the advancement of medical science.
Comparing Innovation Spending: Novo Nordisk A/S and Agios Pharmaceuticals, Inc.
Pfizer Inc. vs Jazz Pharmaceuticals plc: Strategic Focus on R&D Spending
Comparing Innovation Spending: Pfizer Inc. and Corcept Therapeutics Incorporated
R&D Insights: How Pfizer Inc. and Rhythm Pharmaceuticals, Inc. Allocate Funds
Pfizer Inc. vs Dynavax Technologies Corporation: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for Pfizer Inc. and Viridian Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Takeda Pharmaceutical Company Limited and Agios Pharmaceuticals, Inc.
Comparing Innovation Spending: Bio-Techne Corporation and Agios Pharmaceuticals, Inc.
Sarepta Therapeutics, Inc. or Agios Pharmaceuticals, Inc.: Who Invests More in Innovation?
PTC Therapeutics, Inc. vs Agios Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Vericel Corporation and Agios Pharmaceuticals, Inc.
Research and Development Investment: Agios Pharmaceuticals, Inc. vs Iovance Biotherapeutics, Inc.